Search results for "Dizziness"
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
Extended-release metformin recalled due to impurity
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/07/extended-release-metformin-recalled-due-to-impurity.htm
1 Jul 2020
New warning on NSAIDs; drug approved for flu exposures
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/01/new-warning-on-nsaids-drug-approved-for-flu-exposures.htm
1 Jan 2021
FDA analyzing mortality risk with paclitaxel-coated balloons
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/05/fda-analyzing-mortality-risk-with-paclitaxel-coated-balloons.htm
1 May 2019
Warnings about topical antiseptics, nuclear stress test agents
This regulatory update covers label and packaging changes to over-the-counter topical antiseptic products due to infection risk and approval of the first generic versions of rabeprazole sodium for gastroesophageal reflux disease.
https://immattersacp.org/archives/2014/02/fda.htm
1 Feb 2014
Weight-loss drug and at-home HIV test approved
This regulatory update covers approval of lorcaserin HCl for chronic weight management, as well as a new at-home mouth swab test for HIV 1 and 2.
https://immattersacp.org/archives/2012/09/fda.htm
1 Sep 2012
FDA warns about clarithromycin in heart disease
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/05/fda-warns-about-clarithromycin-in-heart-disease.htm
1 May 2018
Cardiac risks of testosterone, saxagliptin under investigation
This regulatory update covers an FDA review of the risk of stroke, heart attack and death in men taking testosterone products, as well as a possible increase in heart failure associated with saxagliptin.
https://immattersacp.org/archives/2014/04/fda.htm
1 Apr 2014
Risks seen with anemia, asthma drugs; insulin syringes recalled
Warnings, recalls and updates from the Food and Drug Administration.
https://immattersacp.org/archives/2010/04/fda.htm
1 Apr 2010
New CBC test, implant for apnea approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/01/new-cbc-test-implant-for-apnea-approved.htm
1 Jan 2018